INHIBITION DE LA VOIE DE COMPLÉMENT ALTERNATIVE POUR LE TRAITEMENT DE LÉSIONS TRAUMATIQUES DU CERVEAU, DE LÉSIONS DE LA MOELLE ÉPINIÈRE ET DE CONDITIONS APPARENTÉES
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODYCORPORATE;MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
发明人:
申请号：
EP06771303.2
公开号：
EP1885398B1
申请日:
2006.05.26
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
Disclosed is the use of agents and compositions that selectively inhibit the alternative complement pathway for the inhibiting or treating physiological damage resulting from traumatic brain injury (TBI), spinal cord injury (SCI), or related conditions. Preferred reagents for use in inhibition of damage resulting from TBI or SCI include those that inhibit factor B, with anti-factor B antibodies representing a particularly preferred agent.
